Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
NovoCure Ltd.
NovoCure Ltd.
University of Kentucky
Dana-Farber Cancer Institute
Peking University
University Medical Centre Maribor
AbbVie
BioAtla, Inc.
Sun Yat-sen University
Hunan Province Tumor Hospital
BioAtla, Inc.
ImmuneSensor Therapeutics Inc.
Wuerzburg University Hospital
Jacobio Pharmaceuticals Co., Ltd.
Chinese PLA General Hospital
Zhejiang Hospital
Jounce Therapeutics, Inc.
Gradalis, Inc.